HIM
FLGT icon

Hillsdale Investment Management’s Fulgent Genetics FLGT Stock Holding History

Hillsdale Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-290
Closed -$7.62K – 703
2025
Q4 		$7.62K Buy
+290
New +$7.52K ﹤0.01% 616
2021
Q1 		– Sell
-105,552
Closed -$5.5M – 588
2020
Q4 		$5.5M Sell
105,552
-500
-0.5% -$20.9K 0.52% 40
2020
Q3 		$4.25M Sell
106,052
-128,300
-55% -$4.02M 0.42% 52
2020
Q2 		$3.75M Sell
234,352
-85,300
-27% -$1.31M 0.34% 75
2020
Q1 		$3.44M Sell
319,652
-73,400
-19% -$1.02M 0.41% 57
2019
Q4 		$5.07M Buy
393,052
+42,152
+12% +$501K 0.44% 54
2019
Q3 		$3.65M Buy
+350,900
New +$3.33M 0.32% 85

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hillsdale Investment Management's FLGT Position: Q1 2026 in Review

Hillsdale Investment Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 290 shares — an estimated $7.62K sold.

Hillsdale Investment Management first reported a position in FLGT in Q3 2019 and held it in 7 quarters. The position peaked at $5.5M in Q4 2020. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Hillsdale Investment Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 290 Fulgent Genetics shares in Q1 2026, an estimated $7.62K.
  • Hillsdale Investment Management first reported a position in Fulgent Genetics in Q3 2019 and held it in 7 quarters.
  • Hillsdale Investment Management's Fulgent Genetics position peaked at $5.5M in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.